TBF (and i share your frustration) there are a couple of things to note:
- The announcement is to do with new distributors - fairly separate to the main game of a commercial partnership with a big player, which requires clinical trial results to be first satisfied (we can debate the merits of the quality of data they have!) Distributors will be doing just that - selling the product in our overseas markets (again we can debate the merits of how effective that is.. or how overpriced the product is etc)
- Savanti distribution partnership was also part of the same announcement, which is fairly established in the UK
- It did point out that Elgenia is new established, which suggests small scale
I think it's important to be measured and on course when showing our frustration, otherwise it can lead to a downward spiral and they are damned if they do and damned if they don't. S'pose you could say they made their bed, they should lie in it.
IMO, and just IMO, the main game centres around the clinical trial results and the strength of a p/ship they can generate on the back of that. If that doesn't come into fruition in the next 6 months, then imma gunna let you finish!
ALT Price at posting:
0.3¢ Sentiment: Hold Disclosure: Held
